LIC Launches 3 New Plans Today: ₹50 Lakh Cancer Cover

Quick Answer

What are LIC's three new plans launching October 19, 2026? New Jeevan Dhara-II (892), a deferred annuity paying lifetime pension at guaranteed rates; Health Shield (907), a fixed-benefit health plan paying hospital cash and lump sums; and New Cancer Cover (908), paying 25% of the sum assured for early-stage cancer, 100% plus monthly income for major-stage cancer. Premiums are undisclosed. On October 13, 2026, LIC told the BSE what was coming next: three new products, unveiled by CEO and MD R. Doraiswamy. Today, October 19, they go on sale. (Reported by the Economic Times and the Free Press Journal, October 13, 2026.) Three launches at once from India's largest insurer is unusual — and two of them sit in a category of insurance most buyers don't fully understand. Here's what each plan pays, how they work, and an honest read on who each one is meant for. One note upfront: LIC disclosed the plan structures in its filing, but premiums, detailed eligibility, benefits and exclusions were not disclosed. Everything below uses only what has been publicly reported — nothing is invented.

The three plans at a glance

New Jeevan Dhara-II (Plan 892) — a non-participating, non-linked individual savings plan: a deferred annuity. You pay premiums now, wait through a deferment period, and then receive a lifetime income. Health Shield (Plan 907) — an individual health plan, pure risk (no savings component). It pays fixed financial benefits for specified health events: hospitalisation, major surgeries and critical illnesses. New Cancer Cover (Plan 908) — another pure-risk individual health plan, focused entirely on cancer. Fixed percentages of the sum assured on diagnosis, plus monthly income for ten years on major-stage cancer. Coverage up to ₹50 lakh. They are available through licensed agents, corporate agents, brokers, insurance marketing firms and LIC's official website.

New Jeevan Dhara-II: the deferred annuity pension

A deferred annuity is simple: you put money in during your working years, wait out a deferment period, and the insurer then pays you a regular income for life. What LIC has disclosed: • Annuity rates are guaranteed and fixed when you buy — you know your future income rate from day one. • Regular or single premium; single-life or joint-life options (joint life keeps paying the surviving spouse). • A top-up annuity facility during the deferment period lets you increase your eventual income. • Minimum entry age 18; deferment of 1 to 15 years. Starting young is the structural advantage of any deferred annuity: a longer deferment runway before the pension begins generally means higher eventual income. LIC has not disclosed the actual rates yet — wait for the policy document before comparing numbers.

Deferred annuity vs NPS

Many under-35 buyers already know the National Pension System. The two products work on very different mechanics: • Jeevan Dhara-II: insurance contract. Annuity rate guaranteed at inception. Income can begin after a deferment of 1 to 15 years. • NPS: market-linked retirement account. Contributions are invested in equity, debt and government securities; the pension depends on market performance and annuity rates at age 60. • Jeevan Dhara-II: no market risk to the rate once locked — but the rate is fixed regardless of later interest-rate moves. • NPS: withdrawals are restricted until age 60, with at least 40% of the corpus annuitised. Neither is objectively better — one locks certainty early, the other trades certainty for market-linked growth. Buyers usually treat them as complements, not substitutes.

To see the NPS side of this equation in numbers, run your contributions through the NPS calculator and compare the projected corpus against a guaranteed annuity quote.

Health Shield: fixed benefits, not reimbursements

This is the plan most people will misunderstand, so let's slow down. India has two fundamentally different kinds of health insurance: • Indemnity (regular mediclaim): reimburses your actual hospital bills, up to the sum insured. It settles bills — nothing more. • Fixed-benefit (what Health Shield is): pays a fixed amount when a specified event happens, regardless of the bill. Hospitalised? You get the daily hospital-cash amount per day. Covered critical illness? You get the defined lump sum. The money is yours to spend on anything — bills, loan EMIs, recovery costs. Fixed-benefit plans do not replace mediclaim; they sit on top of it. Mediclaim settles the bills; the fixed-benefit payout handles everything else. That is the gap Health Shield is aimed at. What LIC has disclosed about Health Shield: • Covers specified health risks: hospitalisation, major surgeries and critical illnesses. • Pays a daily hospital-cash benefit plus lump sums for bigger events. • Entry age 18 to 65; children between 90 days and 20 years can also be covered. • 15-year policy term; guaranteed premiums (no mid-term hikes); optional riders. The honest question before buying any fixed-benefit plan: how much cover is enough? A lump sum that looks generous today can feel thin in five years given medical inflation. Check the defined benefit amounts in the policy document and compare against standalone critical-illness plans before deciding.

New Cancer Cover: the payout math, worked

This is the most precisely disclosed of the three, and the math is pure arithmetic on verified percentages: • Early-stage diagnosis of specified cancers: 25% of the applicable sum assured. • Major-stage diagnosis: 100% of the sum assured, plus a monthly income of 1% of the sum assured for 10 years. • Maximum coverage: ₹50 lakh. Take a ₹10 lakh sum assured: • Early-stage: 25% of ₹10 lakh = ₹2.5 lakh lump sum. • Major-stage: ₹10 lakh lump sum + ₹10,000/month × 120 months (₹12 lakh) = ₹22 lakh total. • At the ₹50 lakh maximum: ₹50 lakh + ₹50,000/month × 10 years = ₹1.1 crore in total nominal payouts. Cancer treatment is long, expensive and income-destroying — and a dedicated payout is designed for exactly that. This structure, with ten years of monthly income on major-stage diagnosis, is genuinely thoughtful design for long treatment cycles.

What LIC has not told us yet

The BSE filing disclosed structures, not commercials. Still unknown as of launch day: • Premium rates for all three plans. • Exact benefit definitions — the specific illnesses covered, the daily hospital-cash figure, the annuity rates. • Full exclusions and waiting periods — where surprises hide in every health plan. Do not buy on launch-day excitement. Read the exclusions section first, compare numbers against existing options, and decide after the policy documents are out. Products bought on day one are bought on marketing, not math.

The honest verdict: who each plan is actually for

This is a map, not a prescription — the right product depends on your existing cover, budget and risk tolerance, and no article can decide that for you. New Jeevan Dhara-II suits buyers who want retirement income certainty locked in early and are comfortable with insurance-based returns rather than market-linked ones. Price it against NPS and other annuities once rates are published. Health Shield suits buyers who already hold a base mediclaim policy and want a cash-in-hand layer on top — especially salaried buyers whose income would stop during a long hospitalisation. It is weaker as a first and only health cover, because fixed benefits do not settle actual hospital bills. New Cancer Cover suits buyers with a family history of cancer or anyone wanting a dedicated, structured payout for the most financially devastating diagnosis there is. One caution for all three: fixed-benefit health products reward careful reading. "Specified health risks" and "specified early-stage diagnosis" do a lot of quiet work in the product descriptions — the fine print decides what actually counts.

Disclaimer: This article is for educational purposes only and is not financial advice. Please consult a SEBI-registered investment adviser for personalized guidance. Investments are subject to market risk. Sources: Economic Times, October 13, 2026 (LIC's BSE regulatory filing announcing the three plans and their October 19, 2026 sale date); Free Press Journal, October 13, 2026 (plan numbers 892/907/908, product features, launch by CEO & MD R. Doraiswamy, availability channels).